These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38549232)

  • 41. Use of Branched-Chain Amino Acids as a Potential Treatment for Improving Nutrition-Related Outcomes in Advanced Chronic Liver Disease.
    Colosimo S; Bertoli S; Saffioti F
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis.
    Fujita M; Abe K; Hayashi M; Takahashi A; Ohira H
    Medicine (Baltimore); 2020 Jul; 99(28):e21061. PubMed ID: 32664122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
    Kawaguchi T; Taniguchi E; Sata M
    Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sarcopenia in cirrhosis: A practical overview.
    Dhaliwal A; Armstrong MJ
    Clin Med (Lond); 2020 Sep; 20(5):489-492. PubMed ID: 32934043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sarcopenia and chronic liver diseases.
    Hsu CS; Kao JH
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1229-1244. PubMed ID: 30791794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term branched-chain amino acid supplementation improves glucose tolerance in patients with nonalcoholic steatohepatitis-related cirrhosis.
    Miyake T; Abe M; Furukawa S; Tokumoto Y; Toshimitsu K; Ueda T; Yamamoto S; Hirooka M; Kumagi T; Hiasa Y; Matsuura B; Onji M
    Intern Med; 2012; 51(16):2151-5. PubMed ID: 22892494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
    Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
    Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.
    Muto Y; Sato S; Watanabe A; Moriwaki H; Suzuki K; Kato A; Kato M; Nakamura T; Higuchi K; Nishiguchi S; Kumada H;
    Clin Gastroenterol Hepatol; 2005 Jul; 3(7):705-13. PubMed ID: 16206505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient-Generated Subjective Global Assessment and Computed Tomography in the assessment of malnutrition and sarcopenia in patients with cirrhosis: Is there any association?
    Zambrano DN; Xiao J; Prado CM; Gonzalez MC
    Clin Nutr; 2020 May; 39(5):1535-1540. PubMed ID: 31307841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of different tools for the evaluation of malnutrition and sarcopenia in patients with liver cirrhosis].
    Aldana Ledesma JM; Vázquez Rodríguez D; Lazcano Becerra M; García Jiménez ES; Tapia Calderón DK; Ibarra Estrada MÁ; Félix Téllez FA; Velarde Ruiz Velasco JA
    Nutr Hosp; 2023 Apr; 40(2):340-346. PubMed ID: 36809904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Controversies in Diagnosing Sarcopenia in Cirrhosis-Moving from Research to Clinical Practice.
    Sinclair M
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31615103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sarcopenia - 2021: Pathophysiology, diagnosis, therapy].
    Pár A; Hegyi JP; Váncsa S; Pár G
    Orv Hetil; 2021 Jan; 162(1):3-12. PubMed ID: 33388736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Assessment and intervention strategies for sarcopenia in patients with liver cirrhosis].
    Xiao HJ; Han T
    Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):199-203. PubMed ID: 33902184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations between sarcopenia and circulating branched-chain amino acids: a cross-sectional study over 100,000 participants.
    Liu H; Zhang Q; Hao Q; Li Q; Yang L; Yang X; Wang K; Teng J; Gong Z; Jia Y
    BMC Geriatr; 2024 Jun; 24(1):541. PubMed ID: 38907227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis.
    Tsien C; Davuluri G; Singh D; Allawy A; Ten Have GA; Thapaliya S; Schulze JM; Barnes D; McCullough AJ; Engelen MP; Deutz NE; Dasarathy S
    Hepatology; 2015 Jun; 61(6):2018-29. PubMed ID: 25613922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
    Praktiknjo M; Clees C; Pigliacelli A; Fischer S; Jansen C; Lehmann J; Pohlmann A; Lattanzi B; Krabbe VK; Strassburg CP; Arroyo V; Merli M; Meyer C; Trebicka J
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00025. PubMed ID: 30939488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients.
    Abdelbasset WK; Nambi G; Elsayed SH; Moawd SA; Ibrahim AA; Verma A; Tantawy SA; Kamel DM; Saleh AK; Aldhafian OR; Nwihadh NB
    Dis Markers; 2021; 2021():8866093. PubMed ID: 33628339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study.
    Lattanzi B; Bruni A; Di Cola S; Molfino A; De Santis A; Muscaritoli M; Merli M
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
    Praktiknjo M; Book M; Luetkens J; Pohlmann A; Meyer C; Thomas D; Jansen C; Feist A; Chang J; Grimm J; Lehmann J; Strassburg CP; Abraldes JG; Kukuk G; Trebicka J
    Hepatology; 2018 Mar; 67(3):1014-1026. PubMed ID: 29059469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review.
    Santangeli E; Abbati C; Chen R; Di Carlo A; Leoni S; Piscaglia F; Ferri S
    Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.